# A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

> **NCT00964223** · PHASE4 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 28 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Clindamycin and benzoyl peroxide gel (Duac® Topical Gel)
- **DRUG:** benzoyl peroxide and adapalene gel (EPIDUO™ Gel)

## Key facts

- **NCT ID:** NCT00964223
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2016-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00964223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00964223, "A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00964223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*